Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-small Cell Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04942301
What this trial is testing

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

Who this might be right for
Advanced or Metastatic NSCLC
Jiangsu Simcere Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT03510611
What this trial is testing

Investigate the Food Effect on the Pharmacokinetics of Ensartinib Capsules in Chinese Healthy Volunteers.

Who this might be right for
Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 24
Large-scale testing (Phase 3)Ended earlyNCT00858364
What this trial is testing

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Who this might be right for
Non-Small Cell Lung CancerAnemiaCancer+1 more
Amgen 2,549
Testing effectiveness (Phase 2)WithdrawnNCT00385398
What this trial is testing

QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC

Who this might be right for
Lung CancerMetastatic Cancer
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)UnknownNCT01019798
What this trial is testing

Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Taipei Medical University Hospital 16
Testing effectiveness (Phase 2)Ended earlyNCT02556593
What this trial is testing

IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases

Who this might be right for
Non-Small Cell Lung Carcinoma
Sun Yat-sen University 12
Testing effectiveness (Phase 2)Study completedNCT00661193
What this trial is testing

S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 59
Testing effectiveness (Phase 2)WithdrawnNCT02466568
What this trial is testing

Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung

Who this might be right for
Lung CancerAdenocarcinoma of the Lung
H. Lee Moffitt Cancer Center and Research Institute
Large-scale testing (Phase 3)Looking for participantsNCT06607796
What this trial is testing

Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy

Who this might be right for
Lung Cancer
Zhou Chengzhi 180
Testing effectiveness (Phase 2)Looking for participantsNCT05379985
What this trial is testing

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Revolution Medicines, Inc. 754
Not applicableStudy completedNCT00573040
What this trial is testing

Radiotherapy for NSCLC to a Individualized MLD

Who this might be right for
Non-small Cell Lung Cancer
Maastricht Radiation Oncology 180
Not applicableStudy completedNCT02843568
What this trial is testing

Improving Pulmonary Function Following Radiation Therapy

Who this might be right for
Non-Small Cell Lung Cancer
University of Wisconsin, Madison 122
Not applicableStudy completedNCT04501497
What this trial is testing

Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

Who this might be right for
Non-small Cell Lung CancerExtensive Disease Small Cell Lung Cancer
Chugai Pharmaceutical 1,221
Early research (Phase 1)Study completedNCT05926180
What this trial is testing

Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19)

Who this might be right for
Non-small Cell Lung Cancer
Dizal Pharmaceuticals 25
Large-scale testing (Phase 3)Ended earlyNCT02974426
What this trial is testing

To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IIIARadiotherapy
Shanghai Chest Hospital 132
Not applicableUnknownNCT03454685
What this trial is testing

The Role of Microbiota on the Development of Lung Cancer

Who this might be right for
NSCLC, Stage INSCLC, Stage IINSCLC, Stage III+2 more
Xiaorong Dong 100
Not applicableStudy completedNCT06495008
What this trial is testing

Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy

Who this might be right for
MelanomaNon-small Cell Lung Cancer (NSCLC)Urogenital Cancers
University Medical Center Groningen 101
Early research (Phase 1)Ended earlyNCT00531076
What this trial is testing

Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer

Who this might be right for
Toxicity
Amsterdam UMC, location VUmc 6
Early research (Phase 1)Study completedNCT00622674
What this trial is testing

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 37
Testing effectiveness (Phase 2)UnknownNCT01503385
What this trial is testing

Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
Chinese Academy of Medical Sciences 100
Next Page